With the explosive popularity of glucagon-like peptide 1 (GLP-1) agonists, physicians say a key avenue in treating obesity is being underutilized by many clinicians: First-generation anti-obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results